DK371886A - Cephalosporinsalte og injicerbare praeparater - Google Patents

Cephalosporinsalte og injicerbare praeparater Download PDF

Info

Publication number
DK371886A
DK371886A DK371886A DK371886A DK371886A DK 371886 A DK371886 A DK 371886A DK 371886 A DK371886 A DK 371886A DK 371886 A DK371886 A DK 371886A DK 371886 A DK371886 A DK 371886A
Authority
DK
Denmark
Prior art keywords
injectable preparations
cephalosporin salts
cephalosporin
salts
injectable
Prior art date
Application number
DK371886A
Other languages
English (en)
Other versions
DK162053B (da
DK371886D0 (da
DK162053C (da
Inventor
Murray A Kaplan
Thomas W Hudyma
Robert A Lipper
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of DK371886D0 publication Critical patent/DK371886D0/da
Publication of DK371886A publication Critical patent/DK371886A/da
Publication of DK162053B publication Critical patent/DK162053B/da
Application granted granted Critical
Publication of DK162053C publication Critical patent/DK162053C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)
DK371886A 1985-08-05 1986-08-04 Temperaturstabile krystallinske salte af 7-oealfa-(2-amino-thiazol-4-yl)-alfa-(z)-methoxyiminoacetamidoaa-3-oe(1-ethyl-1-pyrrolidinium)-methylaa-3-cephem-4-carboxylat, fysiske blandinger af saltene og fremgangsmaade til fremstilling af svovlsyreadditionssaltet DK162053C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76223585A 1985-08-05 1985-08-05
US76223585 1985-08-05

Publications (4)

Publication Number Publication Date
DK371886D0 DK371886D0 (da) 1986-08-04
DK371886A true DK371886A (da) 1987-02-06
DK162053B DK162053B (da) 1991-09-09
DK162053C DK162053C (da) 1992-02-10

Family

ID=25064475

Family Applications (1)

Application Number Title Priority Date Filing Date
DK371886A DK162053C (da) 1985-08-05 1986-08-04 Temperaturstabile krystallinske salte af 7-oealfa-(2-amino-thiazol-4-yl)-alfa-(z)-methoxyiminoacetamidoaa-3-oe(1-ethyl-1-pyrrolidinium)-methylaa-3-cephem-4-carboxylat, fysiske blandinger af saltene og fremgangsmaade til fremstilling af svovlsyreadditionssaltet

Country Status (34)

Country Link
JP (1) JPH0615548B2 (da)
KR (1) KR930003121B1 (da)
AR (1) AR243894A1 (da)
AT (1) AT390957B (da)
AU (1) AU597262B2 (da)
BE (1) BE905219A (da)
CA (1) CA1284994C (da)
CH (1) CH675581A5 (da)
CS (2) CS276717B6 (da)
CY (1) CY1614A (da)
DD (2) DD254941A5 (da)
DE (1) DE3626375A1 (da)
DK (1) DK162053C (da)
EG (1) EG18003A (da)
ES (1) ES2002112A6 (da)
FI (1) FI84484C (da)
FR (1) FR2585705B1 (da)
GB (1) GB2179936B (da)
GR (1) GR862055B (da)
HK (1) HK99691A (da)
HU (1) HU196602B (da)
IE (1) IE59222B1 (da)
IL (1) IL79608A (da)
IT (1) IT1197067B (da)
LU (2) LU88574I2 (da)
MY (1) MY102212A (da)
NL (1) NL8601991A (da)
OA (1) OA08672A (da)
PT (1) PT83134B (da)
SE (1) SE469633B (da)
SG (1) SG79791G (da)
SU (1) SU1516013A3 (da)
YU (1) YU45793B (da)
ZA (1) ZA865842B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4883868A (en) * 1984-12-27 1989-11-28 Banyu Pharmaceutical Co., Ltd. 7-amino-3-(substituted isoindolinium)methyl-3-cephem derivatives
US4959469A (en) * 1984-12-27 1990-09-25 Banyu Pharmaceutical Company, Ltd. Crystalline cephalosporin compounds
US5244891A (en) * 1985-08-05 1993-09-14 Bristol-Myers Squibb Company Injectable compositions of cefepime dihydrochloride hydrate
US4910301A (en) * 1985-08-05 1990-03-20 Bristol-Myers Company Cefepime cephalosporin salts
US4808617A (en) * 1985-12-18 1989-02-28 Bristol-Myers Company Lyophilized or precipitated cephalosporin zwitterion and salt combination
KR950010084B1 (ko) * 1987-06-25 1995-09-06 반유세이야꾸 가부시끼가이샤 결정성 세팔로스포린 화합물, 그의 제조법 및 그의 제조 중간체
JPH02101081A (ja) * 1988-10-08 1990-04-12 Meiji Seika Kaisha Ltd セファロスポリン誘導体結晶性二塩酸塩及びその製造法
CA2011116C (en) * 1989-03-06 1999-11-16 Murray A. Kaplan Lyophilized bmy-28142 dihydrochloride for parenteral use
CA2101571A1 (en) * 1992-09-08 1994-03-09 Elizabeth A. Garofalo Crystalline dihydrate of a cephalosporin dihydrate salt and injectable compositions thereof
ATE202109T1 (de) * 1993-03-12 2001-06-15 Upjohn Co Kristallines ceftiofur (freie säure)
EP0638573A1 (en) * 1993-08-10 1995-02-15 Lucky Ltd. Crystalline hydrates of cephalosporin and process for preparation thereof
ES2298850T3 (es) 2003-12-23 2008-05-16 Sandoz Gmbh Proceso para la produccion de intermedios para utilizar en la sintesis de la cefalosporina.
WO2008056221A2 (en) * 2006-11-06 2008-05-15 Orchid Chemicals & Pharmaceuticals Limited Crystalline sulfate salt of cephalosporin antibiotic
DE102012101680A1 (de) * 2012-02-29 2013-08-29 Aicuris Gmbh & Co. Kg Pharmazeutische Zubereitung enthaltend ein antiviral wirksames Dihydrochinazolinderivat

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55151588A (en) * 1979-05-14 1980-11-26 Takeda Chem Ind Ltd Preparation of cephalosporin salt crystal
CA1213882A (en) * 1982-03-04 1986-11-12 Jun Okumura Cephalosporins
US4406899A (en) * 1982-03-04 1983-09-27 Bristol-Myers Company Cephalosporins
US4525473A (en) * 1983-03-30 1985-06-25 Bristol-Myers Company Cephalosporins
DE3419015A1 (de) * 1984-05-22 1985-11-28 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von cephalosporinen
GB8424692D0 (en) * 1984-10-01 1984-11-07 Glaxo Group Ltd Chemical compounds
GB2165245B (en) * 1984-10-01 1988-05-25 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
AU6069486A (en) 1987-02-12
LU88574I2 (fr) 1995-03-01
ATA211086A (de) 1990-01-15
CA1284994C (en) 1991-06-18
FI863155A7 (fi) 1987-02-06
CS276717B6 (en) 1992-08-12
SU1516013A3 (ru) 1989-10-15
CY1614A (en) 1992-07-10
SE8603308D0 (sv) 1986-08-04
BE905219A (fr) 1987-02-04
IL79608A (en) 1991-07-18
CH675581A5 (da) 1990-10-15
LU86540A1 (fr) 1987-03-06
DK162053B (da) 1991-09-09
DD268395A5 (de) 1989-05-31
IE862078L (en) 1987-02-05
AR243894A1 (es) 1993-09-30
DE3626375A1 (de) 1987-02-12
IT1197067B (it) 1988-11-25
DK371886D0 (da) 1986-08-04
ZA865842B (en) 1987-04-29
AU597262B2 (en) 1990-05-31
FR2585705A1 (fr) 1987-02-06
PT83134A (en) 1986-09-01
FI84484C (fi) 1991-12-10
KR930003121B1 (ko) 1993-04-19
SE8603308L (sv) 1987-02-06
YU137186A (en) 1987-12-31
OA08672A (en) 1989-03-31
GB8618989D0 (en) 1986-09-17
YU45793B (sh) 1992-07-20
AT390957B (de) 1990-07-25
JPH0615548B2 (ja) 1994-03-02
KR880002530A (ko) 1988-05-09
JPS62103090A (ja) 1987-05-13
HUT41802A (en) 1987-05-28
SE469633B (sv) 1993-08-09
NL8601991A (nl) 1987-03-02
IL79608A0 (en) 1986-11-30
HK99691A (en) 1991-12-13
HU196602B (en) 1988-12-28
DK162053C (da) 1992-02-10
CS276849B6 (en) 1992-08-12
FI863155A0 (fi) 1986-08-01
GB2179936B (en) 1989-04-26
FR2585705B1 (fr) 1989-01-13
MY102212A (en) 1992-05-15
PT83134B (pt) 1989-07-31
FI84484B (fi) 1991-08-30
SG79791G (en) 1991-11-15
IT8621409A0 (it) 1986-08-04
GB2179936A (en) 1987-03-18
EG18003A (en) 1991-08-30
IT8621409A1 (it) 1988-02-04
DD254941A5 (de) 1988-03-16
ES2002112A6 (es) 1988-07-16
IE59222B1 (en) 1994-01-26
GR862055B (en) 1986-12-24

Similar Documents

Publication Publication Date Title
DK151686D0 (da) Hydroxamater
DK289886D0 (da) Substituerede 3-phenyl-4-cyanopyrrol-derivater samt deres fremstilling og anvendelse
DK359686D0 (da) Lyofiliserede emulsionsmidler og fremgangsmaade
FR2590799B1 (fr) Seringue
DK371886D0 (da) Cephalosporinsalte og injicerbare praeparater
DK29686A (da) 13beta-alkyl-milbemycinderivater samt deres fremstilling og anvendelse
DK139286D0 (da) Inden- og naphthalenderivater
DK470886A (da) Oxazol- og isoxazolderivater
DK133786D0 (da) Praeparater
DK24986D0 (da) Praeparater
IT1229176B (it) Antibiotici antitumorali bbm-1675c e d
DK172486A (da) Heterocyclyl-penem-forbindelser samt deres fremstilling og anvendelse
DK77286D0 (da) 1-0-acylerede hexosederivater samt deres fremstilling og anvendelse
DE3662889D1 (de) Tetrahydrofurancarboxylic-acid derivatives
FR2588259B1 (fr) Bis-acridiniques monopontes et bis-acridiniques bipontes
DK466086D0 (da) Exogent syrnede antacidiumpraeparater
DK206686D0 (da) Acylaminomethyl-penem-forbindelser samt deres fremstilling og anvendelse
DK363786D0 (da) Hydroquinoliner og anvendelse deraf
DK109086A (da) 2-aminopyrimidinonderivater
DK553285D0 (da) Fenoxypropanolaminsalte og farmaceutiske praeparater deraf
DE3666818D1 (de) Anisole derivatives
DK577286D0 (da) Cephalosporinderivater
DE3662890D1 (de) Furobenzisoxazole derivatives
IT8512566A0 (it) Giunto per mobili
RO93833A2 (ro) Solutie antiacneica si antiseboreica

Legal Events

Date Code Title Description
CTFF Application for supplementary protection certificate (spc) filed

Free format text: CA 1995 00020, 951120

CTFG Supplementary protection certificate (spc) issued

Free format text: CA 1995 00020, 951120, EXPIRES: 20080629

PUP Patent expired